Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 328 entries
View as:

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02177695 Org: User:
Start: 08/28/14 End: 12/01/22 Due: 12/01/23

S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003127 Org: User:
Start: 02/28/98 End: 07/31/04 Due: 07/31/05

S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00023777 Org: User:
Start: 08/31/01 End: 04/30/08 Due: 04/30/09

S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005975 Org: User:
Start: 04/30/98 End: 03/31/02 Due: 03/31/03

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Phase: N/A Priority: Normal
NCT ID: NCT06998940 Org: User:
Start: 01/06/26 End: 12/31/30 Due: 12/31/31

S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00030433 Org: User:
Start: 01/31/02 End: 11/30/08 Due: 11/30/09

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00445601 Org: User:
Start: 09/30/07 End: 06/30/17 Due: 06/30/18

S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00006020 Org: User:
Start: 07/31/00 End: 07/31/04 Due: 07/31/05

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00026520 Org: User:
Start: 11/30/01 End: 04/30/06 Due: 04/30/07

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

Phase: N/A Priority: Normal
NCT ID: NCT05633602 Org: User:
Start: 03/14/23 End: 03/15/28 Due: 03/15/29

S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00107380 Org: User:
Start: 11/30/05 End: 12/31/15 Due: 12/31/16

SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue

Phase: N/A Priority: Normal
NCT ID: NCT00002735 Org: User:
Start: 04/30/96 End: 03/31/05 Due: 03/31/06

S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx

Phase: N/A Priority: Normal
NCT ID: NCT00002999 Org: User:
Start: - End: - Due: -

S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00045617 Org: User:
Start: 01/31/03 End: 05/31/03 Due: 05/31/04

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03887702 Org: User:
Start: 01/17/20 End: 12/20/22 Due: 12/20/23

S0916, MLN1202 in Treating Patients With Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT01015560 Org: User:
Start: 03/31/10 End: 12/31/12 Due: 12/31/13

SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00002563 Org: User:
Start: 04/30/94 End: 05/31/05 Due: 05/31/06

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00127205 Org: User:
Start: 07/31/05 End: 03/29/21 Due: 03/29/22

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00929591 Org: User:
Start: 05/31/89 End: 03/31/10 Due: 03/31/11

S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum

Phase: N/A Priority: Normal
NCT ID: NCT00070434 Org: User:
Start: 08/31/04 End: - Due: -

S0000 Selenium and Vitamin E in Preventing Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006392 Org: User:
Start: 07/31/01 End: 09/30/12 Due: 09/30/13

S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00003911 Org: User:
Start: 07/31/99 End: 08/31/07 Due: 08/31/08

S9304A Study of Protein Expression in Tumor Tissue Samples From Patients With Stage II or Stage III Rectal Cancer Enrolled in Clinical Trial SWOG-9304

Phase: N/A Priority: Normal
NCT ID: NCT00972751 Org: User:
Start: 02/28/09 End: 09/30/10 Due: 09/30/11

S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00233987 Org: User:
Start: 10/31/05 End: 12/31/17 Due: 12/31/18

S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01055301 Org: User:
Start: 07/31/11 End: 07/31/11 Due: 07/31/12